In a report released today, Charles Zhu from LifeSci Capital maintained a Buy rating on IDEAYA Biosciences (IDYA – Research Report), with a ...

Spatial transcriptomics was named the method of the year in 2020 (Nature 2021). Spatial transcriptomics has rapidly emerged ...

Oral Presentation Presented at ASH 2024 Showed Iopofosine I 131 Achieved an 83.6% ORR and Exceeded Primary and Secondary Efficacy Endpoints in ...

Caribou has initiated the GALLOP Phase 1 clinical trial, an open-label, multicenter clinical trial designed to evaluate a single infusion of CB-010 in adult patients with LN and ERL. CB-011, a ...

Genomics, Inc. , a leader in single cell and spatial biology, today announced preliminary, unaudited select results for the fourth quarter and full year ended December 31, ...

QIAGEN N.V. today announced a new plan to return up to approximately $300 million (maximum EUR 281 million) to shareholders through a synthetic share repurchase that combines a direct capital ...

Three blockbuster-potential assets in late-stage clinical trials and four pivotal readouts expected in 2025; anticipate four ...

IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a precision medicine oncology company committed to the discovery and development of ...

The mining industry is undergoing a profound transformation, driven by advancements in precision technology and innovative approaches to tailings management. These advancements are not just ...

An FDA committee’s September 2024 vote to limit the use of Merck’s Keytruda and BMS’ Opdivo in stomach and esophageal cancers ...

Dozens of Massachusetts biotech leaders will be heading to San Francisco this upcoming week for the 2025 J.P. Morgan ...

The Mail On Sunday reports claims that Dominic Cummings is helping orchestrate Elon Musk's attacks on British politicians including Sir Keir Starmer. Rachel Reeves will launch a war on waste to ...